Extra Corporeal Membrane Oxygenation (ECMO) System Market to Grow with a CAGR of 5.36% through 2030
Growing
technological advancements enhancing ECMO system efficiency and safety, and
expanding healthcare infrastructure with increased investment in specialized
critical care facilities, is expected to drive the Global Extra Corporeal
Membrane Oxygenation (ECMO) System Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “Extra Corporeal Membrane Oxygenation (ECMO) System
Market – Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030F”, the Global Extra Corporeal Membrane Oxygenation
(ECMO) System Market stood at USD
571.20 Million in 2024 and is expected to reach USD 782.48 Million by
2030 with a CAGR of 5.36% during the forecast period. The Extracorporeal
Membrane Oxygenation (ECMO) System Market is witnessing substantial growth due
to increasing adoption in critical care settings for managing patients with
severe cardiac and respiratory failure. ECMO systems provide temporary life
support by oxygenating blood outside the body, making them indispensable in
cases of acute respiratory distress syndrome (ARDS), cardiogenic shock, and
post-cardiac surgery recovery. Rising incidences of chronic lung diseases,
coupled with an aging global population, are fueling the demand for ECMO
support. Continuous advancements in perfusion technology and circuit designs
are enhancing the efficiency and safety of ECMO procedures. Expanding
healthcare infrastructure and the establishment of specialized ECMO centers are
facilitating wider adoption, leading to improved patient outcomes and increased
survival rates.
The ECMO System
Market is benefiting from an increasing number of clinical trials and research
studies evaluating its effectiveness in new medical conditions. The integration
of advanced materials in ECMO components is improving biocompatibility, reducing
clotting risks, and extending device longevity. The development of compact and
mobile ECMO units is expanding its use beyond intensive care units (ICUs) to
emergency and transport settings. Growing investments from both public and
private sectors are driving innovation, leading to cost-effective ECMO
solutions tailored for emerging markets. Rising awareness among healthcare
professionals and patients regarding the potential benefits of ECMO therapy is
supporting market growth. Telemedicine and remote patient monitoring are
emerging trends that enhance ECMO management by providing real-time insights
and expert consultations, even in remote locations. The rise in organ
transplantation procedures, where ECMO serves as a bridge to recovery, is
further propelling demand. Strategic collaborations among healthcare
institutions, universities, and medical device manufacturers are fostering new
developments and improving accessibility to ECMO technologies.
Expanding
applications of ECMO therapy in novel areas such as sepsis management and
trauma care present significant growth opportunities for the market. The
increasing focus on neonatal and pediatric ECMO is driving demand for
specialized devices tailored for these patient groups. Emerging markets with
improving healthcare infrastructure are creating opportunities for ECMO
manufacturers to establish partnerships and training programs. The adoption of
automation and artificial intelligence (AI) in ECMO monitoring is expected to
enhance operational efficiency and patient safety. Government initiatives aimed
at increasing funding for critical care technologies are fostering market
growth, making ECMO therapy more accessible across a wider patient population.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Global Extra Corporeal Membrane Oxygenation (ECMO) System Market”
The Global Extra
Corporeal Membrane Oxygenation (ECMO) System Market is segmented into modality,
application, end-user, regional distribution, and company.
Based on the End-User,
Hospitals & Clinics emerged as the fastest growing segment in the Global Extra
Corporeal Membrane Oxygenation (ECMO) System Market during the forecast period.
This is due to the
increasing prevalence of critical respiratory and cardiac conditions,
advancements in ECMO technology, and rising adoption of life-saving procedures.
The demand for ECMO in hospitals and clinics is driven by its ability to
provide prolonged cardiopulmonary support for patients with severe acute
respiratory distress syndrome (ARDS), cardiogenic shock, and post-cardiotomy
heart failure. The expansion of specialized ECMO centers within hospitals has
further fueled growth, as these facilities are better equipped with trained
healthcare professionals and advanced infrastructure. Many healthcare
institutions are integrating ECMO into their intensive care units (ICUs) to
enhance patient survival rates, particularly for those who fail conventional
mechanical ventilation or require cardiac support.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Extra Corporeal Membrane Oxygenation (ECMO) System Market during the forecast period. This is due to the rising incidence of respiratory and cardiovascular diseases,
increasing healthcare investments, and expanding medical infrastructure.
Countries like China, India, and Japan are witnessing a surge in cases of acute
respiratory distress syndrome (ARDS), cardiogenic shock, and post-cardiotomy
heart failure, driving the demand for advanced life-support systems like ECMO. The
region’s growing geriatric population, which is more susceptible to severe
cardiac and pulmonary conditions, has further fueled ECMO adoption.
Additionally, improving healthcare facilities, government initiatives, and
rising awareness about ECMO treatment have contributed to market expansion.
Several leading hospitals in Asia-Pacific are establishing ECMO centers to
enhance critical care capabilities, ensuring better patient outcomes.
Major companies
operating in Global Extra Corporeal Membrane Oxygenation (ECMO) System Market
are:
- LivaNova (Alung Technologies Inc.)
- Eurosets
- Getinge AB
- Medtronic PLC
- Microport Scientific Corporation
- Nipro Medical Corporation
- Terumo Medical Corporation
- Abbott Laboratories
- Fresenius Medical Care Company
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global Extra
Corporeal Membrane Oxygenation (ECMO) System Market is expanding due to the
rising adoption of portable and compact ECMO systems, enabling greater
flexibility in critical care management. Traditional ECMO systems require
stationary setups, limiting their use to intensive care units. However,
advancements in miniaturization and mobility have led to the development of
transport-friendly ECMO devices that can be used in ambulances, air medical
services, and emergency settings. These portable systems enhance accessibility
to life-saving ECMO support for critically ill patients, reducing the time to
intervention and improving survival rates. As healthcare systems emphasize
rapid response and decentralized critical care, the demand for mobile ECMO solutions
is driving market growth.,” said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“Extra Corporeal Membrane
Oxygenation (ECMO) System Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, Segmented By Modality (Veno-Arterial (VA),
Veno-Venous (VV), Others), By Application (Respiratory Applications, Cardiac
Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), By End-User
(Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and
Competition, 2020-2030F”, has evaluated the future growth potential of Global
Extra Corporeal Membrane Oxygenation (ECMO) System Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Extra Corporeal Membrane Oxygenation
(ECMO) System Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com